The Genetic Data Market: Institutional Governance of Academic/Industry Research Partnerships for the Public Good
Year: 2025
Type: article
Abstract: The Trump Administration's cuts to research funding and opposition to diversity, equity, and inclusion is destabilizing academic research. These attacks coincide with pointed government support for the private sector. But the conceptualization of academic versus private sector health research has historically been a false binary. Drawing on mixed methods research, this paper examines the genomic data market as an example of advantages and challenges of commercializing academic expertise. It also highlights the structural downsides of researchers individually navigating industry partnerships. While academia is currently being put in the unenviable position of being more likely to need the private sector to conduct research, with less federal funding to offer in exchange, structural pain points have existed for decades. This is an opportunity for academia to harness its powers of expertise and collective action to develop institutional policy to ensure academic/industry research is beneficial to the public health and diverse patient communities.
Author: Kayte Spector-Bagdady
Institution: University of Michigan
Language: English
Subfield: Pharmacology
Domain: Life Sciences
SDG: Reduced inequalities
Open Access status: hybrid
OpenAlex ID: W4414436653